Diffuse Glioma — Trials

Diffuse Glioma — Trials · CancerIndex

Clinical trials

Registered studies

2,805 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 651–700 of 924 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07244666	Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma	not yet recruiting	Early Phase 1	36	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Nov 24, 2025	clinicaltrials
NCT03233152	A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma.(GlitIpNi)	active not recruiting	Phase 1 / Phase 2